| ²é¿´: 1097 | »Ø¸´: 3 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
lydoctorÒø³æ (СÓÐÃûÆø)
|
[½»Á÷]
Journal of Antimicrobial Chemotherapy ¾Ü¸åºó¿ÉÒÔÐÞ¸ÄÖØÍ¶Â£¿ ÒÑÓÐ1È˲ÎÓë
|
||
|
ÉÏ´ÎͶÁËJournal of Antimicrobial Chemotherapy ÔÓÖ¾£¬ÕûÕû°ë¸öÔÂʱ¼äÒ»Ö±ÊÇunder review£¬ÉõÊÇÇÔϲ£¨Ã»±»¾ÜÔÚÍâÉ󣩣¿Ã»Ï뵽ǰ¼¸ÈÕÊÕµ½Á˱༵ÄÓʼþ˵Í˸壬µ«ÊǸøÁËÒ»µãµãËû×Ô¼ºµÄÒâ¼û£¬Æäʵ¸ù±¾Ã»ÓÐÍâËÍÉó¸å¡£ Editor's comments: The study is of potential interest reporting two Raoultella planticola clinical isolates from China producing AAA and BBB , respectively. However, several studies in the literature have analyzed R. planticloa strains producing CCC as well as other types (DDD) Additionally, the genetic analysis of the current study is rather insufficient. For instance, the integron structure of the BBB-producing strain has not been analyzed. Thus, my recommendation is that the study is of low publication priority for JAC. ĿǰÎÒÒѾ¼Ó×öÁËthe integron structure ·ÖÎö£¬ÕâÑùÇé¿ö¿ÉÒÔ¼ÌÐøÖØÍ¶£¿£¿£¿cover letterÀïÃæÐèÒª°Ñ֮ǰµÄ¸åºÅÒÔ¼°±»¾Ü¸åÇé¿ö˵Ã÷£¿£¿ÁíÍâ¾ÍÊÇÔÚͶ¸åʱºò»¹ÊǼÌÐøÑ¡ÔñÕâ´Î¾ÜÎҵı༣¿£¿£¿ |
» ²ÂÄãϲ»¶
285Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ
ÒѾÓÐ19È˻ظ´
277¹¤¿ÆÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
277Çóµ÷¼Á ÊýÒ»104·Ö
ÒѾÓÐ13È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
336Çóµ÷¼Á£¬Ò»Ö¾Ô¸Öпƴó
ÒѾÓÐ6È˻ظ´
071000ÉúÎïѧ£¬Ò»Ö¾Ô¸ÉîÛÚ´óѧ296·Ö£¬Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ19È˻ظ´
274Çóµ÷¼ÁÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
lydoctor
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 396.9
- É¢½ð: 5
- Ìû×Ó: 57
- ÔÚÏß: 78.3Сʱ
- ³æºÅ: 2396353
- ×¢²á: 2013-04-02
- רҵ: ²¡Ô΢ÉúÎïÓë¸ÐȾÆäËû¿ÆÑ§
3Â¥2014-09-24 21:30:20
goddiao
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 65 (³õÖÐÉú)
- ½ð±Ò: 2291.5
- É¢½ð: 100
- ºì»¨: 14
- Ìû×Ó: 195
- ÔÚÏß: 374.2Сʱ
- ³æºÅ: 2975938
- ×¢²á: 2014-02-18
- ÐÔ±ð: GG
- רҵ: ģʽʶ±ð

2Â¥2014-09-24 21:26:58
goddiao
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 65 (³õÖÐÉú)
- ½ð±Ò: 2291.5
- É¢½ð: 100
- ºì»¨: 14
- Ìû×Ó: 195
- ÔÚÏß: 374.2Сʱ
- ³æºÅ: 2975938
- ×¢²á: 2014-02-18
- ÐÔ±ð: GG
- רҵ: ģʽʶ±ð

4Â¥2014-09-25 08:27:55














»Ø¸´´ËÂ¥